ABPI response to Innovative Medicines Fund announcement

The Government has today launched the Innovative Medicines Fund, to fast track the most promising medicines in the NHS. 

In response to the news, ABPI Chief Executive Richard Torbett said: 

“The Innovative Medicines Fund provides an important opportunity to support NHS patients in getting early access to promising new treatments, including those with rare diseases. 

“If patients are to see maximum benefit from the Fund, industry, the NHS and NICE will need to work closely together to ensure there are no unnecessary barriers for medicines to enter it.  We look forward to seeing more detail on how the Fund will operate in practice.”